Under QIP issue
The QIP Committee of the Board of Directors of Neuland Laboratories approved the allotment of 16,75,000 Equity Shares to eligible qualified institutional buyers at the Issue price of Rs 750 per Equity Share (including a share premium of Rs 740 per Equity Share), aggregating to approximately Rs 125.62 crore.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
